Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by ...

In a significant recognition of its scientific expertise, the Rajiv Gandhi Centre for Biotechnology (BRIC-RGCB) has been selected as one of four national hubs for Next-Generation Sequencing (NGS) ...

In a new paper presented at IEDM 2025, imec reports on the successful fabrication of highly uniform nanopores with diameters ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

While traditional methods like blood tests and microscopic examination remain important, modern technology offers far greater ...

The Rajiv Gandhi Centre for Biotechnology (RGCB) has been selected as one of the four national next-generation sequencing (NGS) hubs for the Metagenomic Syndromic Surveillance Programme under the ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.